Quantcast
Last updated on April 19, 2014 at 9:20 EDT

Latest Bexxar Stories

2013-08-26 23:24:00

In a Breaking News Exclusive, Jamie Reno writes how GSK's spokesperson informed him that Bexxar, a lifesaving cancer drug is being discontinued in February 2014. A 17-year cancer survivor who's been in remission for 13 years because of radio-immunotherapy, Reno discusses the ramifications and reasons behind the cancellation of Bexxar. San Diego, CA (PRWEB) August 26, 2013 According to Jamie Reno, an award-winning correspondent for Newsweek, he received a note from GlaxoSmithKline...

2009-12-08 08:01:00

Long-term Results in both First-line and Refractory Settings Seen in Patients with Non-Hodgkin's Lymphoma PHILADELPHIA, Dec. 8 /PRNewswire/ -- GlaxoSmithKline announced today updated long-term survival data from two Phase II studies of BEXXAR® (tositumomab and iodine I-131 tositumomab) used in either patients with previously untreated cancer of the immune system (follicular lymphoma) or in patients with cancer of the lymphocytes (non-Hodgkin's lymphoma, NHL) that no...

2008-07-29 09:00:23

PHILADELPHIA, July 29 /PRNewswire-USNewswire/ -- Diagnosed with lymphoma, a deadly cancer of the lymphatic system, award-winning Newsweek journalist Jamie Reno felt stunned and alone. What gave him hope was learning of others' successful battles with the disease. His spirits were lifted and today, eleven years later, Jamie Reno has drawn on his experience with the release of Hope Begins in the Dark, a collection of 50 compelling lymphoma survivors' stories. Featuring inspiring personal...

2007-12-23 06:00:09

By Anonymous The U.S. Nuclear Regulatory Commission (NRC) announced in the Federal Register on October 24 that it had denied a petition for rulemaking (PRM35-19) originally submitted by William Stein, III, MD (Metairie, LA), on June 14, 2006. Stein had requested that the NRC amend Title 10 Code of Federal Regulations (CFR) 35 regulations governing training for parenteral administration of ^sup 153^Sm- lexidronam (Quadramet), ^sup 131^I-tositumomab (Bexxar), and ^sup 90^Y-ibritumomab...